A new study published in Ophthalmology Glaucoma highlights the potential of home-based visual field testing to transform how glaucoma is monitored, demonstrating that patients can reliably track disease progression outside of traditional clinical settings. The study evaluated the Melbourne Rapid Fields (MRF) online perimetry system, a digital tool that allows patients to perform visual field tests using standard devices such as laptops or tablets. Researchers found that the platform delivered highly consistent and clinically valid results, supporting its use as a remote monitoring solution for glaucoma. The research, which followed glaucoma patients over a 3-month period, showed that home-based testing using MRF had strong repeatability and agreement with gold-standard in-clinic testing methods, such as the Humphrey Field Analyzer. Participants demonstrated high adherence to the testing protocol, completing multiple at-home assessments with reliable results. The findings suggest that patients can independently conduct meaningful visual field tests without direct supervision, an important step toward more patient-centered care. The MRF system addresses these challenges by enabling remote, web-based testing, which can be performed more frequently and conveniently. This approach could help clinicians identify disease progression earlier while reducing the burden on healthcare systems. The study’s authors concluded that MRF is a “reliable and clinically valid tool” for at-home monitoring, while noting that larger and more diverse studies are needed to confirm its broader applicability. The findings align with a growing trend toward tele-ophthalmology and digital health solutions, particularly for chronic conditions like glaucoma that require ongoing management. If validated in larger populations, home-based visual field testing could play a key role in decentralizing eye care, improving access for patients in underserved regions, and enabling more proactive disease management. Reference 1. Kong G, Dirani N, et al. Reliability and agreement of home-based visual field testing using Melbourne Rapid Fields in glaucoma. Ophthalmol Glaucoma. 2025;S2589-4196(25)00240-6. doi:10.1016/j.ogla.2025.00240
